Glenmark Pharmaceuticals Update by Epic Research

Glenmark Pharmaceuticals is currently trading at Rs. 742.85, up by 7.70 points or 1.05% from its previous closing of Rs. 735.15 on the BSE.

The scrip opened at Rs. 738.00 and has touched a high and low of Rs. 754.00 and Rs. 738.00 respectively. So far 15521 shares were traded on the counter.

Glenmark Pharmaceuticals’ first in class Transient Receptor Potential Ankyrin 1 (TRPA1) antagonist, GRC 17536 has shown positive data in a Phase 2a double blind, placebo controlled, multi-centre, proof of concept study conducted on 138 patients in Europe and India.

Real Time News & Trading Trends Keep Liking Epic Research Private Limited

Facebook – Twitter – YouTube – Pinterest –Linkedin - Google+

For more information ✆ – 0731-6642300 or Visit http://www.epicresearch.co